Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Smoking Cessation 1 Motor Activity 1 Lung Neoplasms 1 Inflammation 1

Interventions

Cisplatin 3202 Cyclophosphamide 3195 Carboplatin 2977 Radiotherapy 2790 Paclitaxel 2718 Gemcitabine 2572 pembrolizumab 2385 Bevacizumab 2209 Docetaxel 2199 Fluorouracil 1851 Capecitabine 1833 Oxaliplatin 1742 Dexamethasone 1605 Nivolumab 1581 Doxorubicin 1501 Rituximab 1488 Magnetic Resonance Spectroscopy 1387 Etoposide 1346 Irinotecan 1248 Leucovorin 1226 Drug Therapy 1205 Cytarabine 1130 Pemetrexed 1076 fludarabine 1063 Specimen Handling 1017 Vincristine 964 Cetuximab 945 Trastuzumab 945 Prednisone 942 Lenalidomide 937

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

cytisine × Clear all

NCT03654105 2026-03-27

SMILE

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Active not recruiting

Inflammation, Lung Neoplasms, Motor Activity, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡